Panax notoginseng Saponins Attenuate Oxygen-Glucose Deprivation/Reoxygenation-Induced Injury in Human SH-SY5Y Cells by Regulating the Expression of Inflammatory Factors through miR-155
-
- Meng Lanqing
- Department of Neurology, Affiliated Hospital of Youjiang Medical College for Nationalities
-
- Lin Jun
- Department of Neurology, Affiliated Hospital of Youjiang Medical College for Nationalities
-
- Huang Qing
- Department of Neurology, Affiliated Hospital of Youjiang Medical College for Nationalities
-
- Liang Ping
- Department of Neurology, Affiliated Hospital of Youjiang Medical College for Nationalities
-
- Huang Jianmin
- Department of Neurology, Affiliated Hospital of Youjiang Medical College for Nationalities
-
- Jian Chongdong
- Department of Neurology, Affiliated Hospital of Youjiang Medical College for Nationalities
-
- Lin Chong
- Department of Neurology, Affiliated Hospital of Youjiang Medical College for Nationalities
-
- Li Xuebin
- Department of Neurology, Affiliated Hospital of Youjiang Medical College for Nationalities
書誌事項
- タイトル別名
-
- <i>Panax notoginseng</i> Saponins Attenuate Oxygen–Glucose Deprivation/Reoxygenation-Induced Injury in Human SH-SY5Y Cells by Regulating the Expression of Inflammatory Factors through miR-155
この論文をさがす
抄録
<p>Panax notoginseng saponins (PNS) have been widely used in China to treat stroke. Accumulating evidence has found that microRNA (miR)-155 plays critical roles in the pathology of ischemic stroke. Here we investigated whether PNS plays a protective effect against oxygen–glucose deprivation/reoxygenation (OGD/R)-induced focal inflammation and injury in SH-SY5Y cells by regulating miR-155 expression. Treatment with PNS at a concentration less than 160 µg/mL had no effect on the proliferation of SH-SY5Y cell. In OGD/R-induced SH-SY5Y cells, 160 µg/mL PNS treatment promoted cell proliferation and cell cycle progression, as well as decreased inhibited apoptosis and miR-155 expression. However, overexpression of miR-155 attenuated the promotion effects of PNS on cell proliferation and cell cycle, apoptosis inhibition in OGD/R-induced SH-SY5Y cells. Moreover, 160 µg/mL PNS treatment decreased the levels of interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α) in OGD/R-induced SH-SY5Y cells, whereas overexpression of miR-155 reversed PNS-induced decreases in the levels of IL-1β, IL-6, and TNF-α in OGD/R-treated SH-SY5Y cells. In conclusion, PNS attenuated OGD/R-induced injury in human undifferentiated SH-SY5Y cells by regulating the expression of inflammatory factors through miR-155.</p>
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 42 (3), 462-467, 2019-03-01
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001288125164288
-
- NII論文ID
- 130007605938
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 029543700
-
- PubMed
- 30587668
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可